During Q2, Unity Biotechnology (NASDAQ: UBX) saw earnings decrease by 14.02%, resulting in a loss of $23.35 million. In Q1, Unity Biotechnology lost $27.16 million in earnings. Why ROCE Is Significant ...
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...
Detailed price information for Unity Software Inc (U-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results